ArticleInvestigational new drugs2022

The kinesin Eg5 inhibitor K858 exerts antiproliferative and proapoptotic effects and attenuates the invasive potential of head and neck squamous carcinoma cells.

Alice Nicolai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.